Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Perimeter Medical Imaging AI ( (TSE:PINK) ).
Perimeter Medical Imaging AI plans to cancel up to 2,175,619 previously issued employee and consultant stock options, which carry exercise prices between C$0.38 and C$2.85, and replace them with an equal number of options exercisable at C$0.30. The new options, which retain the original expiry dates and exclude directors and officers, will vest monthly on varying schedules starting January 1, 2026, and the repricing remains subject to TSX Venture Exchange approval.
The move effectively lowers the exercise price on a substantial portion of staff equity awards, aiming to restore the incentive value of options that are likely out of the money and better align employee compensation with the company’s current share price. If approved, the change could help Perimeter retain and motivate key personnel as it seeks to commercialize its imaging technologies and strengthen its competitive position in the cancer surgery market.
The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.24 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on TSE:PINK Stock
According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.
The score is held down primarily by weak financial quality (persistent losses and negative operating/free cash flow) despite solid gross margins and revenue growth, and by bearish technicals with the stock trading below key moving averages. Valuation adds limited support because the negative P/E reflects ongoing losses and no dividend yield is available.
To see Spark’s full report on TSE:PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a commercial-stage medical technology company focused on transforming cancer surgery through ultra-high-resolution, real-time imaging tools that address areas of high unmet medical need. Based in Toronto and Dallas, it markets the FDA-cleared Perimeter S-Series OCT system in the U.S. and is advancing its investigational B-Series OCT with ImgAssist AI for next-generation, AI-enabled intraoperative imaging.
Average Trading Volume: 117,052
Technical Sentiment Signal: Sell
Current Market Cap: C$37.83M
For a thorough assessment of PINK stock, go to TipRanks’ Stock Analysis page.